December 2002
Volume 43, Issue 13
Free
ARVO Annual Meeting Abstract  |   December 2002
The Clinical Importance of Ocular Perfusion Pressure Calculation With Systemic Medication
Author Affiliations & Notes
  • LE Kagemann
    Ophthalmology Indiana Univ Sch of Med Indianapolis IN
  • A Harris
    Ophthalmology Indiana Univ Sch of Med Indianapolis IN
  • AB Yee
    Ophthalmology Indiana Univ Sch of Med Indianapolis IN
  • AL Coleman
    Ophthalmology Jules Stein Eye Inst Los Angeles CA
  • LJ McCranor
    Ophthalmology Indiana Univ Sch of Med Indianapolis IN
  • RJ Toft
    Ophthalmology Indiana Univ Sch of Med Indianapolis IN
  • B Siesky
    Ophthalmology Indiana Univ Sch of Med Indianapolis IN
  • S Shah
    Ophthalmology Indiana Univ Sch of Med Indianapolis IN
  • M Zalish
    Ophthalmology Kaplan Med Center Rehovot Israel
  • Footnotes
    Commercial Relationships   L.E. Kagemann, None; A. Harris, None; A.B. Yee, None; A.L. Coleman, None; L.J. McCranor, None; R.J. Toft, None; B. Siesky, None; S. Shah, None; M. Zalish, None. Grant Identification: SIFI (Italy), Unrestricted grant from Research to prevent blindness
Investigative Ophthalmology & Visual Science December 2002, Vol.43, 331. doi:
  • Views
  • Share
  • Tools
    • Alerts
      ×
      This feature is available to authenticated users only.
      Sign In or Create an Account ×
    • Get Citation

      LE Kagemann, A Harris, AB Yee, AL Coleman, LJ McCranor, RJ Toft, B Siesky, S Shah, M Zalish; The Clinical Importance of Ocular Perfusion Pressure Calculation With Systemic Medication . Invest. Ophthalmol. Vis. Sci. 2002;43(13):331.

      Download citation file:


      © ARVO (1962-2015); The Authors (2016-present)

      ×
  • Supplements
Abstract

Abstract: : Purpose:To evaluate the influence of altered blood pressure (BP), heart rate, and intraocular pressure (IOP) on ocular perfusion pressure (PP) with a systemic alpha adrenergic antagonist. Methods:Blood pressure, heart rate, and IOP OU of fifteen normal subjects, (twelve male and three female, with a mean age of 27.3 8.88 years), were taken before and two hours after 60 mg PO nicergoline. Baseline and post-drug measurements were compared by paired Wilcoxin ranked sum test. Linear regression was used to compare percent change of each parameter with PP ( PP = 2/3 of MAP- IOP). Results:There was no significant change in blood pressure or heart rate as compared to baseline measurements. IOP was significantly decreased (p = 0.003 OD and 0.0191 OS). The percent change in PP was significantly correlated with change in systolic blood pressure (p = 0.0002, r2 = 0.736), diastolic blood pressure (p < 0.0001, r2 = 0.857), and heart rate (p = 0.0229, r2= 0.388). There was no significant correlation with PP and IOP. Conclusion:Ocular perfusion pressure is calculated from blood pressure and IOP, however changes in PP may not correlate with measured changes in median IOP, despite significant changes in IOP. Calculating PP is helpful when evaluating the effect of systemic and ocular drugs, specifically those that may affect blood pressure, IOP, or both.

Keywords: 331 blood supply • 444 intraocular pressure • 514 pharmacology 
×
×

This PDF is available to Subscribers Only

Sign in or purchase a subscription to access this content. ×

You must be signed into an individual account to use this feature.

×